| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | Regnante Keith | Chief Financial Officer | Nov 04, 2023 | Option Exercise | $30.65 | 80,000 | 2,451,600 | 40,000 | Jan 08, 2024, 04:43 PM | |
| KROS | Keros Therapeutics, Inc. | Regnante Keith | Chief Financial Officer | Jun 08, 2023 | Option Exercise | $31.90 | 40,000 | 1,275,872 | 20,000 | Jun 12, 2023, 04:13 PM | |
| KROS | Keros Therapeutics, Inc. | Regnante Keith | Chief Financial Officer | Jun 09, 2023 | Sale | $30.71 | 40,000 | 1,228,367 | 20,000 | Jun 12, 2023, 04:13 PM | |
| WVE | Wave Life Sciences Ltd. | Regnante Keith | Chief Financial Officer | Feb 19, 2019 | Sale | $36.84 | 1,298 | 47,818 | 15,686 | Feb 21, 2019, 07:54 PM | |
| WVE | Wave Life Sciences Ltd. | Regnante Keith | Chief Financial Officer | Sep 24, 2018 | Sale | $37.94 | 59,000 | 2,238,755 | 46,484 | Sep 26, 2018, 06:59 PM | |
| WVE | Wave Life Sciences Ltd. | Regnante Keith | Chief Financial Officer | Feb 16, 2018 | Sale | $51.85 | 316 | 16,385 | 16,984 | Feb 21, 2018, 07:16 PM |
Menu